STAGE III RECTAL CANCER AJCC V7
Clinical trials for STAGE III RECTAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RECTAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III RECTAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat colon cancer
Disease control CompletedThis study tested which of two drug combinations worked better to control advanced colorectal cancer that had a specific genetic feature called HER2 amplification. The trial involved 240 patients whose cancer had spread and could not be removed by surgery. One group received two …
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Apr 01, 2026 20:10 UTC
-
New hope for rectal cancer: trial tests boosting treatment before surgery
Disease control CompletedThis study tested whether adding one of two new drugs (veliparib or pembrolizumab) to standard chemotherapy and radiation could better shrink rectal tumors before surgery. It involved 363 patients with locally advanced rectal cancer that had not spread to distant organs. The goal…
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC